Class Action

Robitussin Non-Drowsy Claims

Class Action

Robitussin Non-Drowsy Claims


Case Name (Date)

Papalia et al. v GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
22-cv-2630, S.D.N.Y.
(March 2022)


Product/Service

Robitussin


Allegations

Falsely marketing products as non-drowsy when an ingredient (dextromethorphan, or DXM) in them causes drowsiness


Status

Pending



Class-Action Tracker

Abreva

Class Action

Abreva

Allegations: Misleadingly marketing Abreva cold sore treatments


The Latest

Filters